Question-and-Answer SessionMaybe just to kick things off, obviously, impressive Phase II data readout last week that investors were looking for. Maybe at a topline, can you just briefly summarize, I guess, first, how this trial was conducted? And if you want to try and touch on the novel trial design and then maybe hit the high points of the efficacy that you saw and then you can kind of drill down into the details.Abraham CeesayCEO, President, Treasurer & Director Sure. Happy to, Joe, and I really apprecia ...